Silent Myocardial Ischaemia, CKD a Deadly Combination: Presented at NKF By Carole VanSickle Ellis
ORLANDO, Fla -- April 19, 2010 -- A study examining the relationship between silent myocardial ischaemia (SMI) and chronic kidney disease (CKD) shows that the 2 conditions combined are often fatal.
In fact, patients with both CKD and SMI had a lower chance of long-term survival than any other group in the study, researchers said here on April 16 at the National Kidney Foundation (NKF) 2010 Spring Clinical Meetings.
Ammar Almehmi, MD, Division of Nephrology, University of Kansas' Kidney Institute, Kansas City, Kansas, and colleagues enrolled 356 men and women who had undergone percutaneous coronary intervention (PCI).
SMI was defined, for the purposes of this study, as the absence of chest pain in response to the PCI. Estimated glomerular filtration rate (eGFR) was used to categorise patients as having normal renal function, mild renal dysfunction, moderate renal dysfunction, and severe renal dysfunction.
Compared with patients with normal renal function, the multivariable adjusted hazard ratios for all-cause mortality among patients with mild, moderate, and severe renal impairment were 1.11, 1.75, and 2.79, respectively.
Patients with both eGFR <=60 mL/min and SMI had a worse survival compared with those with eGFR >60 and no SMI.
Given that the prevalence of sudden cardiac death among patients on dialysis is 20 to 100 times higher than the general population, these findings may underlie the increased mortality in patients with depressed eGFR, the researchers said.
The researchers were also able to conclude that eGFR is a graded and independent predictor of long-term mortality in patients with CAD.
[Presentation title: Silent Myocardial Ischemia and Chronic Kidney Disease: The Fatal Dance. Abstract 36]
http://www.docguide.com/news/content.nsf/news/852576140048867C8525770A0051F8AF